These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38931189)

  • 1. Role of Body Composition in Patients with Resectable Pancreatic Cancer.
    Pecchi A; Valoriani F; Cuoghi Costantini R; Squecco D; Spallanzani A; D'Amico R; Dominici M; Di Benedetto F; Torricelli P; Menozzi R
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
    Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
    BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
    Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
    Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
    Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
    Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505.
    Sohal DPS; Boutin RD; Lenchik L; Kim J; Beg MS; Wang-Gillam A; Wade JL; Guthrie KA; Chiorean EG; Ahmad SA; Lowy AM; Philip PA; Chang VT
    J Gastrointest Surg; 2024 Mar; 28(3):232-235. PubMed ID: 38445914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer.
    Guarneri G; Pecorelli N; Bettinelli A; Campisi A; Palumbo D; Genova L; Gasparini G; Provinciali L; Della Corte A; Abati M; Aleotti F; Crippa S; De Cobelli F; Falconi M
    Eur J Surg Oncol; 2024 May; 50(5):106848. PubMed ID: 36863915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
    Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
    Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
    Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
    Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
    Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High visceral fat attenuation and long-term mortality in a health check-up population.
    Lee JH; Choi SH; Jung KJ; Goo JM; Yoon SH
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1495-1507. PubMed ID: 37016984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer.
    Takeda T; Sasaki T; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
    Jpn J Clin Oncol; 2021 Apr; 51(4):604-611. PubMed ID: 33479765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery.
    Pecorelli N; Carrara G; De Cobelli F; Cristel G; Damascelli A; Balzano G; Beretta L; Braga M
    Br J Surg; 2016 Mar; 103(4):434-42. PubMed ID: 26780231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of body composition in patients with digestive tract cancers: A prospective cohort study of 8,267 adults from China.
    Han J; Liu X; Wang J; Tang M; Xu J; Tan S; Liu X; Wu G
    Clin Nutr ESPEN; 2024 Aug; 62():192-198. PubMed ID: 38901941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative sarcopenia determinants in pancreatic cancer patients.
    Carrara G; Pecorelli N; De Cobelli F; Cristel G; Damascelli A; Beretta L; Braga M
    Clin Nutr; 2017 Dec; 36(6):1649-1653. PubMed ID: 27789123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment.
    Bongers MER; Groot OQ; Buckless CG; Kapoor ND; Twining PK; Schwab JH; Torriani M; Bredella MA
    Spine J; 2022 Apr; 22(4):595-604. PubMed ID: 34699994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.